🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To estimate the response rate, response duration, clinical benefit, and tox...
Status
Completed
Location
ILEX Oncology Inc
Start Date
TBD
Trial ID
NCT00002348
Treatments Being Tested
2 different formulations and 4 different single doses of tafamidis will be ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-09-28
Trial ID
NCT03662191
Treatments Being Tested
Assessment of the association of maxillary expansion using a rapid palatal ...
Status
Completed
Location
CHU de Rennes
Start Date
2017-11-05
Trial ID
NCT03267927
Treatments Being Tested
This phase II trial tests how well a combination of three immunotherapy dru...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-11-08
Trial ID
NCT06056895
This phase I/II trial tests the safety, side effects best dose and effect o...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-06-23
Trial ID
NCT07468136
Despite the suggestions that GA and frailty indices could be used to guide ...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2019-04-26
Trial ID
NCT04158726
Treatments Being Tested
This phase II trial tests how well retifanlimab with bevacizumab and hypofr...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-10-02
Trial ID
NCT06160206
3 different formulations and doses of tafamidis will be compared. Subjects ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2016-04
Trial ID
NCT02697864
Treatments Being Tested
The purpose of this study is to evaluate the safety and activity of two dos...
Status
Unknown
Location
Barzilai Medical Center
Start Date
2010-02
Trial ID
NCT00956332
Treatments Being Tested
This phase II trial studies the effect of retifanlimab and telotristat ethy...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-03-01
Trial ID
NCT04776876
Treatments Being Tested